AEAlexander Nikolaevich Evstropov

Alexander Nikolaevich Evstropov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander Nikolaevich Evstropov has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Combined Oral Contraceptives as a Risk Factor for Antimycotic Resistance in Recurrent Vulvovaginal Candidiasis: The Importance of Sensitivity Testing Methods for Treatment Optimization

    by Tatyana Mikhailovna Sokolova, Alexander Nikolaevich Evstropov, Lyudmila Nikolaevna Zakharova, Tatyana Vyacheslavovna Kiseleva, Konstantin Yuryevich Makarov, Vasilya Rashitovna Mukhamedshina, Yulia Alexandrovna Pimenova, Anna Vladimirovna Usova, Ekaterina Viktorovna Folyak

  • Electron beam crosslinking of polyethylene glycol for the developing an hydrogel- and peptidomimetic-based antimicrobial drug

    by P.G. Madonov, S.V. Mishenina, E.A. Bondareva, A.N. Evstropov, D.V. Yaroslavtsev, M.S. Soldatova, D.V. Klyuev, E.M. Lyubushkina, M.A. Korolev

    Introduction. Currently, the search for alternatives to conventional antibiotics, as well as for materials that do not exert an irritating effect on the body but can serve as a depot for antimicrobial substances, is highly relevant. The idea of developing a composition of a modified polyethylene glycol-based gel and an antimicrobial peptidomimetic is consi­dered promising. Aim. To study the physico-chemical processes of electron beam crosslinking of polyethylene glycol (PEG) in order to obtain a hydrogel with required properties and develop a depot-matrix for an antimicrobial peptidomimetic based on this technology. Materials and methods. PEGs with a molecular weight of 400–40 000 Da was exposed to radiation, which involves polymer degradation and crosslinking. Their properties were studied, and a composition based on PEG and the antimicrobial peptidomimetic CAMP-1 (tripeptide H-Arg-Tbt-Arg-NH-C2H4-Ph) was developed. Results. The gel was obtained using low-molecular-weight PEG and a radiation dose of 1,5–3 Mrad or high-mole­cular-weight PEG (over 4000 Da) and a radiation dose of 0,25 Mrad. To achieve gel formation by crosslinking, we used low-molecular-weight PEG (1,500 Da) and a radiation dose of 2 Mrad. The antibacterial peptidomimetic CAMP-1 was implanted into the gel obtained without technological complexity using a rotary homogenizer. An increase in the radiation dose led to a proportional decrease in gel flowability. Conclusion. Varying the electron beam exposure parameters and PEG concentration allows to obtain hydrogels with the required properties for a depot-matrix intended to implant pharmacologically active agents. CAMP-1 is retained in a gel-like depot-matrix, and the diffusion of this peptidomimetic into the aqueous phase occurs at low intensity. Developing this technology of an antimicrobial drug makes it possible to produce prototypes of finished dosage forms for topical use.

  • Analysis of the Potential Clinical Application of the Peptidomimetic SAMP-1 to Eliminate Biofilms Caused by S. Aureus

    by Bondareva Elena Alexandrovna, Evstropov Alexander Nikolaevich, Madonov Pavel Gennadievich, Burova Lubov Georgievna, Lyubushkina Elizaveta Mikhailovna

    The article presents the data of «in vitro» study of a new synthetic antimicrobial peptidomimetic SAMP-1 as an effective drug for biofilm elimination. S. aureus strain ATCC 6538 FDA was used as a test culture. A model of staphylococcal biofilm was created according to Litusov's method. The possibility of preventing the creation of biofilms and destruction of already formed microbial conglomerates by means of the test substance was evaluated.

  • Sensitivity of pathogenic and opportunistic microorganisms to probiotic strains in the light of personalized probiotic therapy

    by Anastasia I. Parakhina, Larisa I. Parakhina, Darya A. Troshina, Katerina E. Levina, Yulia A. Pimenova, Elena N. Koteneva, Aleksandr N. Evstropov, Liudmila N. Zakharova, Andrey Yu. Mironov, Tatyana G. Suranova

    BACKGROUND: Resistance of microorganisms to antimicrobial drugs (AMP) is one of the global problems of modern medicine, which poses a serious threat to human health. The formation of the resistance of pathogens to AMP forces us to look for new ways to combat them. Probiotic therapy is one of the promising and safe methods of treating many infectious diseases. AIM: This study assesses the sensitivity of clinical strains of pathogenic and opportunistic bacteria and fungi to microorganisms that are part of probiotic preparations. MATERIALS AND METHODS: The sensitivity of 93 cultures of pathogenic and opportunistic microorganisms (UPM) isolated from the feces of patients with intestinal dysbiosis to strains of probiotic bacteria isolated from commercial probiotic preparations was studied: Lactobacillus plantarum 8RA-3, Escherichia coli M-17, Bacillus subtilis strain VKPM B-10641, Enterococcus faecium SF-68, Saccharomyces boulardii CNCM I-745 by the delayed antagonism method. RESULTS: Pathogenic microorganisms showed low and moderate sensitivity to the probiotic strain of L. plantarum. Sensitivity to the probiotic strain of B. subtilis was detected in Staphylococcus aureus strains, low or completely absent in Pseudomonas aeruginosa, Klebsiella spp., Serratia marcescens. The most sensitive to the probiotic strain were clinical strains of E. coli. CONCLUSION: UPM and pathogenic microorganisms isolated from the gastrointestinal tract of patients with dysbiosis have different sensitivity to probiotic strains: from high to several probiotics to its complete absence. The empirical approach to prescribing a probiotic does not guarantee a therapeutic effect, which makes it prudent to individualize the selection of a probiotic based on an assessment of its antimicrobial activity against isolated pathogens.


  • Study of the antibacterial properties of new caffeine derivatives against opportunistic pathogenic bacteria in vitro

    by E.A. Bondareva, D.V. Reshetnikov, L.G. Burova, S.S. Patrushev, L.N. Zakharova, A.N. Evstropov, E.E. Schults

    Introduction. The resistance of microbes to many classes of antimicrobial drugs is a global threat to human health and necessitates the search for new compounds with antimicrobial activity, with low toxicity and a potentially wide range of biological activity. Aim. To study in vitro the ability of new xanthine derivatives (caffeine, 1-butyltheobromine and 7-butyltheophylline) to inhibit growth Staphylococcus (S.) aureus, Bacillus (B.) cereus, Escherichia (E.) coli and Pseudomonas (P.) aeruginosa. Materials and methods. The antibacterial activity of xanthine derivatives synthesized in the Laboratory of Medicinal Chemistry of the N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry was studied in vitro using serial dilutions in a liquid nutrient medium against S. aureus, B. cereus, E. coli and P. aeruginosa cultures. Results. Three substances, including the starting material – caffeine and 7-butyltheophylline, did not show antibacterial properties against test microbes. All xanthine derivatives studied did not inhibit the growth of E. coli and P. aeruginosa; 9 compounds containing fragments of amino acid esters or an acetylene substituent in the position of the C-8 xanthine backbone showed antibacterial activity against S. aureus and (or) B. cereus. Conclusion. When studying the ability of natural xanthine caffeine and 12 of its derivatives to inhibit the growth of cultures of opportunistic bacteria, antibacterial properties against S. aureus and B. cereus were revealed in a number of amino acid derivatives. The best effect was shown by compounds containing fragments of alpha- and beta-amino acid esters (L-valine and beta-phenyl-beta-alanine), which determines the prospects for further research.


  • Open Access

    Recovery strategies intestinal mucosal barrier

    by A. A. Khryanin, M. F. Osipenko, O. B. Nemchaninova, O. N. Pozdnyakova, T. B. Reshetnikova, A. N. Evstropov

    The surface of the intestinal tract in healthy people is free of bacteria in all segments of the intestine. Thus, the attachment of bacteria to epithelial cells is a sign of infection. Unlike the mucous membrane, the intestinal lumen is never sterile. The reason for this is the polymicrobial nature of the gut microbiota. In the intestine, segments such as the stomach or small intestine, where bacteria are actively suppressed, the microbiota is random in appearance, composition, and concentration. However, the situation is completely different in the colon, where the growth of bacteria increases and their suppression is suspended. The concentration and diversity of bacteria in the colon reaches astronomical numbers. Some of these bacteria are required for the colon to function. Many of the local bacteria in the colon are potential pathogens: Bacteroides, Enterobacteriaceae, Enterococci, and Clostridium histolyticum. Control of pathogens in the colon is achieved through an impenetrable mucus layer. Inflammatory bowel disease is a polymicrobial infection characterized by persistent disruption of the mucosal barrier, subsequent migration of bacteria to the mucous membrane, and overgrowth of a complex bacterial biofilm on the surface of the epithelium, resulting in invasive and cytopathological effects. As long as the mucosal barrier function is impaired, the inflammatory process cannot successfully remove bacteria from the mucosal surface, and inflammation itself is detrimental. Due to the inflammatory reaction, the composition and structure of the fecal microbiota changes. Based on the biostructure of the fecal casts, active Crohn’s disease and ulcerative colitis can be distinguished from each other and from other gastrointestinal diseases. The relationship between the gut microbiome and various dermatological diseases (psoriasis, acne, rosacea, atopic dermatitis) is discussed.